EUVIMEDEUVIMED entdecken
Crossref

Elaiophylin targets EIF4B to suppress the growth of esophageal squamous cell carcinoma via the PI3K/AKT signaling pathway

Hu Qiu, Lijuan Gao, Wei Shi, Jing Wang, Bin Li, Shaobo Ke, Jiamei Chen, Yi Gong, Yong Wu, Wensi Zhao, Yongshun Chen

Cancer Letters · 2025

DOI: 10.1016/j.canlet.2024.217401 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2025. Verfasst von Hu Qiu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Center, Renmin Hospital of Wuhan University, Wuhan 430064, China. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-akt, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, Phosphatidylinositol 3-Kinases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Elaiophylin is known to exert antitumor effects through certain signaling pathways; however, no reports regarding its effects on esophageal cancer are available. This study explored the effects of elaiophylin in esophageal squamous cell carcinoma (ESCC) cells. Transwell and immunofluorescence assays confirmed that elaiophylin inhibited the migration and proliferation of ESCC cells, and western blotting assays showed that it affected apoptosis-related gene expression in ESCC cells. Based on RNA-seq analyses, Single-cell RNA-seq, a human cancer pathway phosphorylation antibody array, and Gene Ontology and Kyoto Encyclopedia of Genes and Genomics analyses, we found that elaiophylin was related to low expression of EIF4B and activation of the phosphoinositide 3-kinase (PI3K)/AKT signaling pathway. In both in vitro and in vivo experiments, ESCC cells treated with elaiophylin showed low EIF4B expression, which inhibited their proliferation and promoted apoptosis by activating the PI3K/AKT signaling pathway; EIF4B overexpression could reverse these effects of elaiophylin on ESCC cells. Therefore, our results indicate that elaiophylin targets EIF4B to inhibit ESCC cell proliferation via the PI3K/AKT signaling pathway. Targeting elaiophylin or the EIF4B/PI3K/AKT signaling pathway may produce new methods for ESCC treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins c-aktEsophageal Squamous Cell CarcinomaEsophageal NeoplasmsPhosphatidylinositol 3-KinasesEukaryotic Initiation FactorsHumansSignal TransductionCell ProliferationAnimalsCell Line, TumorApoptosisCell MovementMiceXenograft Model Antitumor AssaysGene Expression Regulation, NeoplasticMice, Nude

Stichwörter der Autor:innen

EIF4BElaiophylinEsophageal squamous cell carcinomaPI3K/AKT

Substanzen

Proto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinaseseIF-4BEukaryotic Initiation Factors

Autor:innen und Institutionen

  • Cancer Center, Renmin Hospital of Wuhan University, Wuhan 430064, China.
  • Cancer Center, Renmin Hospital of Wuhan University, Wuhan 430064, China; Cancer Center, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, 518033, China. Electronic address: yongshun2007@163.com.

Zitieren

APA

Qiu, H., Gao, L., Shi, W., Wang, J., Li, B., Ke, S., Chen, J., Gong, Y., Wu, Y., Zhao, W., & Chen, Y. (2025). Elaiophylin targets EIF4B to suppress the growth of esophageal squamous cell carcinoma via the PI3K/AKT signaling pathway. Cancer Letters. https://doi.org/10.1016/j.canlet.2024.217401

Vancouver

Qiu H, Gao L, Shi W, Wang J, Li B, Ke S, et al. Elaiophylin targets EIF4B to suppress the growth of esophageal squamous cell carcinoma via the PI3K/AKT signaling pathway. Cancer Letters. 2025. doi:10.1016/j.canlet.2024.217401

BibTeX
@article{Qiu2025,
  author = {Qiu, Hu and Gao, Lijuan and Shi, Wei and Wang, Jing and Li, Bin and Ke, Shaobo and Chen, Jiamei and Gong, Yi and Wu, Yong and Zhao, Wensi and Chen, Yongshun},
  title = {Elaiophylin targets EIF4B to suppress the growth of esophageal squamous cell carcinoma via the PI3K/AKT signaling pathway},
  journal = {Cancer Letters},
  year = {2025},
  doi = {10.1016/j.canlet.2024.217401}
}
Kostenlos starten →